beta blocker: be contraindicated in asthma

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents agent
Weight: 0.65
, high blood pressure
Weight: 0.63
, heart disease
Weight: 0.63
, vasodilator
Weight: 0.62
Siblings atenolol
Weight: 0.53
, lung cancer
Weight: 0.33
, cystic fibrosis
Weight: 0.33
, agonist
Weight: 0.32
, blood clot
Weight: 0.32

Related properties

Property Similarity
be contraindicated in asthma 1.00
be contraindicated with asthma 1.00
be contraindicated in patients with asthma 0.98
be contraindicated in diabetes 0.95
be contraindicated in disease 0.94
be contraindicated in angina 0.94
be contraindicated in vasospastic angina 0.94
be contraindicated in diabetes mellitus 0.94
be contraindicated in copd 0.94
be contraindicated in in raynaud 0.94

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.07
Rule weight: 0.13
Evidence weight: 0.50
Similarity weight: 1.00
Evidence: 0.77
¬ Remarkable(beta blocker, be contraindicated in asthma)
Evidence: 0.65
¬ Remarkable(atenolol, be contraindicated in asthma)

Remarkability from sibling implausibility

0.55
Rule weight: 0.60
Evidence weight: 0.92
Similarity weight: 1.00
Evidence: 0.69
Plausible(beta blocker, be contraindicated in asthma)
Evidence: 0.65
Remarkable(atenolol, be contraindicated in asthma)
Evidence: 0.75
¬ Plausible(atenolol, be contraindicated in asthma)

Salient implies Plausible

0.21
Rule weight: 0.28
Evidence weight: 0.75
Similarity weight: 1.00
Evidence: 0.69
Plausible(beta blocker, be contraindicated in asthma)
Evidence: 0.84
¬ Salient(beta blocker, be contraindicated in asthma)

Similarity expansion

0.74
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 1.00
Evidence: 0.84
Salient(beta blocker, be contraindicated in asthma)
Evidence: 0.79
¬ Salient(beta blocker, be contraindicated with asthma)
0.72
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 1.00
Evidence: 0.77
Remarkable(beta blocker, be contraindicated in asthma)
Evidence: 0.68
¬ Remarkable(beta blocker, be contraindicated with asthma)
0.71
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.98
Evidence: 0.84
Salient(beta blocker, be contraindicated in asthma)
Evidence: 0.87
¬ Salient(beta blocker, be contraindicated in patients with asthma)
0.71
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.94
Evidence: 0.84
Salient(beta blocker, be contraindicated in asthma)
Evidence: 0.66
¬ Salient(beta blocker, be contraindicated in copd)
0.71
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.94
Evidence: 0.84
Salient(beta blocker, be contraindicated in asthma)
Evidence: 0.66
¬ Salient(beta blocker, be contraindicated in in raynaud)
0.71
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.98
Evidence: 0.77
Remarkable(beta blocker, be contraindicated in asthma)
Evidence: 0.67
¬ Remarkable(beta blocker, be contraindicated in patients with asthma)
0.70
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.94
Evidence: 0.84
Salient(beta blocker, be contraindicated in asthma)
Evidence: 0.79
¬ Salient(beta blocker, be contraindicated in vasospastic angina)
0.70
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.95
Evidence: 0.84
Salient(beta blocker, be contraindicated in asthma)
Evidence: 0.85
¬ Salient(beta blocker, be contraindicated in diabetes)
0.69
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.95
Evidence: 0.77
Remarkable(beta blocker, be contraindicated in asthma)
Evidence: 0.66
¬ Remarkable(beta blocker, be contraindicated in diabetes)
0.69
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.94
Evidence: 0.84
Salient(beta blocker, be contraindicated in asthma)
Evidence: 0.87
¬ Salient(beta blocker, be contraindicated in diabetes mellitus)
0.69
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.94
Evidence: 0.77
Remarkable(beta blocker, be contraindicated in asthma)
Evidence: 0.64
¬ Remarkable(beta blocker, be contraindicated in vasospastic angina)
0.68
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.94
Evidence: 0.67
Typical(beta blocker, be contraindicated in asthma)
Evidence: 0.44
¬ Typical(beta blocker, be contraindicated in in raynaud)
0.68
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.94
Evidence: 0.77
Remarkable(beta blocker, be contraindicated in asthma)
Evidence: 0.68
¬ Remarkable(beta blocker, be contraindicated in diabetes mellitus)
0.68
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.94
Evidence: 0.69
Plausible(beta blocker, be contraindicated in asthma)
Evidence: 0.50
¬ Plausible(beta blocker, be contraindicated in in raynaud)
0.67
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.94
Evidence: 0.69
Plausible(beta blocker, be contraindicated in asthma)
Evidence: 0.53
¬ Plausible(beta blocker, be contraindicated in copd)
0.67
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 1.00
Evidence: 0.69
Plausible(beta blocker, be contraindicated in asthma)
Evidence: 0.69
¬ Plausible(beta blocker, be contraindicated with asthma)
0.67
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.94
Evidence: 0.67
Typical(beta blocker, be contraindicated in asthma)
Evidence: 0.50
¬ Typical(beta blocker, be contraindicated in copd)
0.66
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.94
Evidence: 0.77
Remarkable(beta blocker, be contraindicated in asthma)
Evidence: 0.74
¬ Remarkable(beta blocker, be contraindicated in copd)
0.66
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.94
Evidence: 0.77
Remarkable(beta blocker, be contraindicated in asthma)
Evidence: 0.79
¬ Remarkable(beta blocker, be contraindicated in in raynaud)
0.65
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 1.00
Evidence: 0.67
Typical(beta blocker, be contraindicated in asthma)
Evidence: 0.72
¬ Typical(beta blocker, be contraindicated with asthma)
0.63
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.98
Evidence: 0.69
Plausible(beta blocker, be contraindicated in asthma)
Evidence: 0.78
¬ Plausible(beta blocker, be contraindicated in patients with asthma)
0.63
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.94
Evidence: 0.69
Plausible(beta blocker, be contraindicated in asthma)
Evidence: 0.70
¬ Plausible(beta blocker, be contraindicated in vasospastic angina)
0.62
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.95
Evidence: 0.69
Plausible(beta blocker, be contraindicated in asthma)
Evidence: 0.76
¬ Plausible(beta blocker, be contraindicated in diabetes)
0.61
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.98
Evidence: 0.67
Typical(beta blocker, be contraindicated in asthma)
Evidence: 0.82
¬ Typical(beta blocker, be contraindicated in patients with asthma)
0.61
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.94
Evidence: 0.69
Plausible(beta blocker, be contraindicated in asthma)
Evidence: 0.78
¬ Plausible(beta blocker, be contraindicated in diabetes mellitus)
0.61
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.94
Evidence: 0.67
Typical(beta blocker, be contraindicated in asthma)
Evidence: 0.74
¬ Typical(beta blocker, be contraindicated in vasospastic angina)
0.60
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.95
Evidence: 0.67
Typical(beta blocker, be contraindicated in asthma)
Evidence: 0.80
¬ Typical(beta blocker, be contraindicated in diabetes)
0.59
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.94
Evidence: 0.67
Typical(beta blocker, be contraindicated in asthma)
Evidence: 0.81
¬ Typical(beta blocker, be contraindicated in diabetes mellitus)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.84
Salient(beta blocker, be contraindicated in asthma)
Evidence: 0.67
¬ Typical(beta blocker, be contraindicated in asthma)
Evidence: 0.77
¬ Remarkable(beta blocker, be contraindicated in asthma)

Typical implies Plausible

0.38
Rule weight: 0.48
Evidence weight: 0.79
Similarity weight: 1.00
Evidence: 0.69
Plausible(beta blocker, be contraindicated in asthma)
Evidence: 0.67
¬ Typical(beta blocker, be contraindicated in asthma)

Typicality and Rermarkability incompatibility between siblings

0.05
Rule weight: 0.14
Evidence weight: 0.39
Similarity weight: 1.00
Evidence: 0.77
¬ Remarkable(beta blocker, be contraindicated in asthma)
Evidence: 0.79
¬ Typical(atenolol, be contraindicated in asthma)